Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Dysplastic Nevi for Dummies: Histopathology
Description
The presentation focuses on the histopathology of dysplastic nevi, highlighting the controversies and challenges in terminology and classification among dermatopathologists. Despite a notable turnout and engagement from the audience, the speaker addresses issues such as the lack of consensus on nomenclature, with only about 25% concordance rate among dermatopathologists when classifying dysplastic nevi. The importance of standardized definitions, like those proposed by the EMpath effort, is emphasized to improve research and clinical application. The histopathology features that characterize dysplastic nevi include architectural and cytological atypia, which are graded as mild, moderate, or severe depending on their resemblance to melanoma. The speaker provides visual examples to illustrate these categories, explaining how even slight differences in cellular arrangement and morphology can indicate varying levels of risk. The discourse concludes with an acknowledgment of the need for a uniform approach in diagnosing and studying melanocytic lesions to better understand their biological implications and improve accuracy in diagnosis. Ultimately, while some may see dysplastic nevi as a direct spectrum to melanoma, the speaker prompts the audience to consider the complexities that question that simplicity.
View moreConclusions
- There is significant controversy and a lack of consensus regarding the histopathology of dysplastic nevi among dermatopathologists.
- The concordance rate for terminology usage among dermatopathologists is very low, approximately 25%.
- Even within the same dermatopathologist, there can be variability in grading when assessing specimens at different times.
- Dysplastic nevi constitutes a small portion of melanocytic lesions, suggesting it may not be as significant as once believed.
- Standardizing nomenclature and definitions for dysplastic nevi is crucial for clinical and research purposes, as highlighted by efforts like empath.
- The relationship between histological appearance and biological behavior of dysplastic nevi may not be as straightforward as previously assumed.
- Green AR, Moshiri A, Hippe DS, Raymundo C, Piepkorn M, Shinohara MM. Differences in nomenclature usage and preference among dermatopathologists for "dysplastic" nevi: A national survey. J Cutan Pathol. 2023 Jun;50(6):530-535. doi: 10.1111/cup.14341. Epub 2023 Apr 3. PMID: 36239041.
- Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813.
- Piepkorn MW, Barnhill RL. "Common Acquired and Atypical/Dysplastic Melanocytic Nevi." Pathology of Melanocytic Nevi and Melanoma, 3rd Edition. Springer, 2014.
- Barnhill RL, Elder DE, Piepkorn MW, Knezevich SR et al. Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement. JAMA Netw Open. 2023 Jan 3;6(1):e2250613. doi: 10.1001/jamanetworkopen.2022.50613. PMID: 36630138; PMCID: PMC10375511.